Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome

Objective  To examine the relationship between antepartum buprenorphine dose for medication-assisted treatment (MAT) of opioid use disorder (OUD) and incident neonatal opioid withdrawal syndrome (NOWS). Study Design  We performed a prospective cohort study of pregnant women with a singleton gestatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavan, Niraj R., Ashford, Kristin B., Wiggins, Amanda T., Lofwall, Michelle R., Critchfield, Agatha S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720890/
https://www.ncbi.nlm.nih.gov/pubmed/29226017
http://dx.doi.org/10.1055/s-0037-1608783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720890/
https://www.ncbi.nlm.nih.gov/pubmed/29226017
http://dx.doi.org/10.1055/s-0037-1608783

Ejemplares similares